Mathilde Cancel
Centre Hospitalier Universitaire de Tours(FR)Hôpital Bretonneau(FR)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Sarcoma Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Renal and related cancers
Most-Cited Works
- → Efficacy of Savolitinib vs Sunitinib in Patients WithMET-Driven Papillary Renal Cell Carcinoma(2020)177 cited
- → Recurrent PRKAR1A Mutation in Acrodysostosis with Hormone Resistance(2011)177 cited
- → Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial(2022)128 cited
- → Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial(2023)71 cited
- → Effects of in vivo static compressive loading on aggrecan and type II and X collagens in the rat growth plate extracellular matrix(2008)68 cited
- → Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study(2022)49 cited
- → Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study(2021)47 cited
- → The Calcium-Sensing Receptor is A Marker and Potential Driver of Neuroendocrine Differentiation in Prostate Cancer(2020)32 cited
- → Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study(2023)28 cited
- → Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario(2022)26 cited